BioCare Copenhagen
BioCare Copenhagen is a Danish bio-venture that develops proprietary Microbiome Targeted Technology (MTT) and a Humiome® portfolio of probiotics, postbiotics, synbiotics, and vitamin B2 ingredients for dietary supplement, nutrition, and pharmaceutical manufacturers.
- Company typePrivate
- Founded2012
- HeadquartersCopenhagen, Denmark
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What BioCare Copenhagen does
BioCare Copenhagen is a Danish bio-venture founded in 2012 and headquartered in Copenhagen, operating in the human gut-health ingredients space. The company develops and supplies microbiome-targeted dietary supplement ingredients built on a proprietary Microbiome Targeted Technology (MTT) platform, which enables targeted release of vitamins and biotics in the lower intestine and colon. Its commercial portfolio, marketed under the Humiome® brand, spans probiotics, postbiotics, synbiotics, and the differentiated Humiome® B2 ingredient that releases approximately 90% of its vitamin B2 content in the lower intestine to support gut microbiome health.
The company's technology differentiates it within the broader biotics market through (i) targeted colonic delivery rather than generic release, (ii) postbiotic formats offering extended shelf life and dry-powder manufacturability, and (iii) custom biotics premix and market-ready formulation services that reduce time-to-market for brand partners. Customer segments are horizontal and include dietary supplement manufacturers (primary), early life nutrition producers, medical nutrition formulators, and pharma solutions customers.
BioCare Copenhagen operates as a private, for-profit company with 11–50 employees. Its go-to-motion is B2B ingredient supply combined with formulation/premix services to enterprise customers in the supplement, nutrition, and pharmaceutical industries. Pricing is not publicly disclosed. The company was seeded by Borean Innovation in 2013 and is led by CEO Soren B. Thomsen. Several market research sources cited (postbiotics ~9.3% CAGR, eubiotics ~9.7% CAGR, older-adult supplements growing to ~$278B by 2032) indicate a structurally growing addressable market, though BioCare Copenhagen's own revenue capture within these markets is not disclosed.
BioCare Copenhagen firmographics
Firmographics- Name
- BioCare Copenhagen
- Website
- https://biocarecph.com
- Company type
- Private
- Founded year
- 2012
- Headcount range
- 11–50 employees
- Short description
- BioCare Copenhagen is a Danish bio-venture that develops proprietary Microbiome Targeted Technology (MTT) and a Humiome® portfolio of probiotics, postbiotics, synbiotics, and vitamin B2 ingredients for dietary supplement, nutrition, and pharmaceutical manufacturers.
- Ownership category
- akta.pro rank
BioCare Copenhagen industry classification
Industry- Product category
- Dietary Supplement Ingredients
- NAICS
- Biological Product (except Diagnostic) Manufacturing (325414)
- SIC
- Pharmaceutical Preparations (2834), Biological Products, (No Disgnostic Substances) (2836)
- akta.pro primary industry
- Probiotics & Digestive Health Supplements (CRADAGAF)
- akta.pro secondary industries
- Protective Cultures & Biopreservation (Anti-Listeria, Anti-Mold, Shelf-Life Cultures) (AFAJAJAF), Bio-based Pharmaceuticals, Nutraceuticals & Specialty Bioactives (EUAAAIAK)
Keywords
Where BioCare Copenhagen is headquartered
LocationHeadquarters
- HQ city
- Copenhagen
- HQ country
- Denmark
- HQ region
- Europe
Markets served
BioCare Copenhagen business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Operations
Distribution channels2 records
Marketing channels4 records
BioCare Copenhagen product offering
Product offeringCore offering
BioCare Copenhagen is a bio-venture company that develops and supplies microbial dietary supplement ingredients, including probiotics, postbiotics, and synbiotics, underpinned by its proprietary Microbiome Targeted Technology (MTT). The company formulates clinically documented, IP-protected biotics offerings (including the Humiome® portfolio and Humiome® B2) and offers custom biotics premixes and market-ready solutions to manufacturers in the dietary supplement, early life nutrition, medical nutrition, and pharmaceutical sectors.
Differentiator
Problem solved
Functional benefit
Products and services
- Humiome® Probiotics Live microorganism preparations supplied as ingredients to dietary supplement manufacturers and brands, conferring gut health benefits when administered in adequate amounts. Targeted at supplement, early life nutrition, and functional food formulators.
- Humiome® Postbiotics Preparations of inanimate microorganisms and/or their components that confer health benefits (digestive, metabolic heart, immunity, brain). Sold as a stable dry-powder ingredient to supplement and nutrition manufacturers.
- Humiome® Synbiotics Combinations of probiotics and prebiotics designed to deliver more than the sum of their parts. Supplied to infant nutrition and dietary supplement manufacturers targeting microbiome health benefits.
- Humiome® B2 with Microbiome Targeted Technology (MTT) Vitamin B2 ingredient delivered with patented prebiotic-like benefits for the gut microbiome. Releases approximately 90% of vitamin B2 in the lower intestine and colon, supporting bacterial metabolism, gut resilience, and protection against oxidative stress. Marketed to supplement manufacturers seeking differentiated gut-health nutrition.
- Custom Biotics Premix and Market-Ready Solutions Custom-formulated biotics premixes and ready-to-market blends enabling brand partners to accelerate product development. Offered to enterprise customers through direct consultation and application services.
Quantifiable outcome
- Humiome® B2 releases ~90% of vitamin B2 in the lower intestine and colon
- +4 more outcomes
Companies that use BioCare Copenhagen
Customer profileSegments4 records
Ideal customer profiles4 records
BioCare Copenhagen technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
BioCare Copenhagen partnerships and signals
Strategic signalScale indicators5 records
Expansion highlights3 records
BioCare Copenhagen competitors and assessment
Company assessmentMarket position
Competitive moat2 records
Key risks5 records
Key highlights5 records
Customer concentration
BioCare Copenhagen social profiles
Digital presenceBioCare Copenhagen financial estimates
Financial estimateRevenue estimate
Valuation estimate
BioCare Copenhagen leadership team
Management profileNumber of profiles
Profiles1 record
BioCare Copenhagen funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
BioCare Copenhagen M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about BioCare Copenhagen
What does BioCare Copenhagen do?
BioCare Copenhagen is a bio-venture company that develops and supplies microbial dietary supplement ingredients, including probiotics, postbiotics, and synbiotics, underpinned by its proprietary Microbiome Targeted Technology (MTT). The company formulates clinically documented, IP-protected biotics offerings (including the Humiome® portfolio and Humiome® B2) and offers custom biotics premixes and market-ready solutions to manufacturers in the dietary supplement, early life nutrition, medical nutrition, and pharmaceutical sectors.
When was BioCare Copenhagen founded?
BioCare Copenhagen was founded in 2012. It employs 11 to 50 people.
Where is BioCare Copenhagen based?
BioCare Copenhagen is headquartered in Copenhagen, Denmark, in the Europe region.
Does BioCare Copenhagen have an API?
No public API is recorded for BioCare Copenhagen.
What industry is BioCare Copenhagen in?
BioCare Copenhagen's product category is Dietary Supplement Ingredients. Its primary akta.pro industry code is CRADAGAF, Probiotics & Digestive Health Supplements, with a secondary code of AFAJAJAF, Protective Cultures & Biopreservation (Anti-Listeria, Anti-Mold, Shelf-Life Cultures). Its NAICS code is 325414 and its SIC code is 2834.